Novartis’s $90 million Swiss factory to help solve cell therapy bottleneck
ZURICH (Reuters) – Swiss drugmaker Novartis’s (NOVN.S) new $90 million cell and gene therapy factory in northern Switzerland is on…
Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ
FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30,…
Novartis to buy U.S. biotech The Medicines Co. for $9.7 billion
ZURICH (Reuters) – Novartis AG (NOVN.S) is buying U.S. biotechnology company The Medicines Co (MDCO.O) for about $9.7 billion, the…
Novartis arthritis drug fails to prove it is significantly better than rival
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland…
Novartis wins FDA’s breakthrough tag for lung cancer hopeful
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland…
Novartis, Lonza deepen biosimilars push with MS, arthritis drug deals
ZURICH (Reuters) – Swiss drugmakers Novartis and Lonza separately deepened their push into so-called biosimilars, betting cheaper copies of name-brand…
UK cost watchdog recommends Novartis’ blindness therapy Luxturna
(Reuters) – Novartis AG’s gene therapy for blindness, Luxturna, is recommended for use on England’s public health service, the country’s…
Novartis takes aim at Roche’s star MS drug
ZURICH (Reuters) – Swiss drugmaker Novartis on Friday stepped up its challenge to Roche’s multiple sclerosis franchise, highlighting study results…
Novartis executive sold shares before drug data manipulation made public
VIENNA (Reuters) – An unnamed Novartis executive sold 925,400 Swiss francs ($946,000) worth of shares less than three weeks before…
Novartis executive sold shares before drug data manipulation made public
VIENNA (Reuters) – An unnamed Novartis executive sold 925,400 Swiss francs ($946,000) worth of shares less than three weeks before…
Novartis replaces top scientists at Avexis after drug data manipulated
NEW YORK (Reuters) – Novartis AG said on Wednesday it replaced the two top research and development executives at its…
Novartis names Bulto as new head of U.S. drugs business
FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel, Switzerland, March 29, 2018.…
Novartis says top R&D executives no longer at Avexis unit after test data manipulation
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland…
Senator Grassley seeks info on Novartis’s Zolgensma data issues
FILE PHOTO: U.S. Senator Chuck Grassley (R-IA) speaks to reporters on his way from the Senate floor after a vote…
Novartis’s older MS drug Gilenya wins Chinese approval
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland…
Novartis to sell epinephrine shot in U.S. pharmacies amid EpiPen shortage
(Reuters) – Novartis AG (NOVN.S) said on Tuesday it would make its generic pre-filled epinephrine shots immediately available in local…
Novartis to sell epinephrine injector in U.S. pharmacies amid EpiPen shortage
FILE PHOTO: EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen…
U.S. group says Novartis MS drug price out of line with benefit
ZURICH (Reuters) – A U.S. group that reviews the value of medicines issued a critical report on Novartis’s new multiple…
Novartis CEO plans gene therapy price ‘far lower’ than $4 million to $5 million range
FILE PHOTO: The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017.…
Second death in Novartis gene therapy trials under investigation
(Reuters) – Novartis AG, which this week announced positive interim trial results for its experimental gene therapy for spinal muscular…
Swiss drugmaker Novartis must face doctor kickback suit, U.S. judge rules
NEW YORK (Reuters) – Novartis AG must face a U.S. government lawsuit accusing it of paying millions of dollars in…
Swiss drugmaker Novartis must face doctor kickback suit, U.S. judge rules
NEW YORK (Reuters) – Novartis AG must face a U.S. government lawsuit accusing it of paying millions of dollars in…
Novartis gene therapy would be cost effective up to $900,000: U.S. group
(Reuters) – An experimental gene therapy for spinal muscular atrophy (SMA) developed by Swiss drugmaker Novartis AG would be worth…
Novartis sells U.S. generics assets to India’s bargain-hunting Aurobindo
ZURICH/BENGALURU (Reuters) – New Novartis Chief Executive Vas Narasimhan has further reshaped the Swiss drugmaker, announcing on Thursday he is…
Novartis readies anti-sexism message for migraine drug
ZURICH (Reuters) – With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to…
Novartis top lawyer exits in wake of Trump attorney deal
ZURICH (Reuters) – Novartis (NOVN.S) General Counsel Felix Ehrat will leave the Swiss drugmaker over his role in a $1.2…
Novartis ditches lawyer as head rolls over Trump lawyer deal
ZURICH (Reuters) – Novartis (NOVN.S) General Counsel Felix Ehrat will leave the Swiss drugmaker over his role in a $1.2…